THESE MEDICATIONS ARE MOSTLY KNOWN FOR TREATING DIABETES AND OBESITY.. BUT THE F-D-A HAS APPROVED THEM FOR PREVENTING HEART DISEASE AFTER STUDIES LAST FALL. THAT SHOWED ABOUT A 20% REDUCTION IN ...

The United States has been experiencing a shortage of ADHD medications since October 2022 and, just when things seemed to get ...

Corcept Therapeutics' long-term goal is $3 billion revenue by 2029, driven by the new drug Relacorilant. Click here to read ...

A flurry of executive orders and other actions Trump issued on his first day back in office included rescinding directives by his predecessor, former President Joe Biden, that had promoted lowering ...

Trump rescinded Executive Order 14087, "Lowering Prescription Drug Costs for Americans," which directed Medicare and Medicaid ...

Inflation was a top issue that helped propel Donald Trump back into the White House. But actions the new president has taken in his first days on the job could hit Americans - particularly seniors - ...

President Trump's first executive orders on health provide a possible road map that health researchers say could increase the number of uninsured Americans and weaken safety net protections for ...

With a sweep of the pen, President Donald Trump has ended a Biden administration effort to lower the cost of prescription ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

An asthma drug taken by hundreds of thousands of Australians could increase the risk of suicide, research suggests.

An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration ...